Letzte Aktualisierung: December 15, 2020

Peru stops Sinopharm test

In the development of its Covid vaccine, Chinese manufacturer Sinopharm has suffered a setback. As reported by Deutsche Welle, Peru has suspended clinical tests of the company's vaccine due to health problems in test subjects. The United Arab Emirates was the only country to have approved the Chinese vaccine in early December, the first time details about the effectiveness of a Chinese vaccine had been made public. In the crucial third phase of the trial, the vaccine was found to be 86 percent effective, according to the Emirati Ministry of Health. In China itself, in addition to Sinopharm with Anhui Zhifei Longcom, CanSino and Sinovac, three other companies are in the final stages of vaccine development. Final approval domestically has not yet been granted to any of the companies, but this is expected in the coming days. China has set a target of bringing 600 million doses to market by the end of the year. State media have been reporting for weeks about restricted vaccinations of certain groups of the population – such as military personnel and hospital staff, but also diplomats and employees of state-owned companies. Sinopharm alone says it has already administered its vaccine to more than one million people. gko
Testimonial Random Image
Please use HAN to get access to this article.
Secure your information advantage

Exclusive, highly topical and expert information for your industry: In our Professional Briefings, our more than 60 specialized journalists report from Berlin, Brussels and Beijing.

  • All issues by e-mail
  • Access to the web portal and the archive
  • For the decisive minds from politics, business and science

No payment data. No automatic renewal.

Select Professional Briefings

*free of charge even after the trial period has expired

Das Late-Night-Memo für die Hauptstadt: Exclusive Meldungen + Pressebriefing

Jeden Morgen die 100 relevantesten Schlagzeilen aus über 1.000 Quellen

Das Leitmedium für die deutschsprachige China-Berichterstattung

Europäische Regulierungen, EU-Energie- und Klimaschutzpolitik, Industriestrategie und Finanzpolitik

Das unabhängige Briefing für Bildungs-Politik, -Strategie und -Forschung

Klimapolitik anderer Staaten und der Europäischen Union, sowie die ganze Breite der internationalen Klimadebatte

Sicherheitslage und -strategie, Verteidigungspolitik und Beschaffung von Militärtechnologie

Für zukunftsfähiges Wirtschaften: Nachhaltigkeitspolitik und Transformationsstrategien

Wissenschaftspolitik, Forschungsstrategie, Innovationsmanagement und Research Funding

Wirtschaftliche Trends, deutsche und internationale Afrika-Politik und Investitionschancen

Regulierung im Agrar- und Lebensmittelsektor auf nationaler und europäischer Ebene

With a focus on the German government and EU Commission, global corporations and medium-sized companies

European regulation, EU climate and environmental policy and innovation to trade and finance

Information during the global hot season - with in-depth analyses on all aspects of the global transformation

How may we address you?

Your registration was successful.

Welcome to Table.Media.
You will receive an email with a confirmation link.
Please click on this link to complete your registration.

You have not received an email?

  • Please check your spam folder.
  • Maybe you have registered with a different email address?
  • Please check if you have misspelled your email address.